LONAFARNIB

作品数:8被引量:3H指数:1
导出分析报告
相关领域:医药卫生更多>>
相关作者:苗莹贾娴张文竹刘国娟孙韬华更多>>
相关机构:广西医科大学复旦大学青岛市市立医院沈阳药科大学更多>>
相关期刊:《World Journal of Gastroenterology》《Gastroenterology Report》《中国处方药》《Signal Transduction and Targeted Therapy》更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Signal Transduction and Targeted Therapyx
条 记 录,以下是1-1
视图:
排序:
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein
《Signal Transduction and Targeted Therapy》2024年第7期2970-2983,共14页Qi Yang Bao Xue Fengjiang Liu Yongzhi Lu Jielin Tang Mengrong Yan Qiong Wu Ruyi Chen Anqi Zhou Lijie Liu Junjun Liu Changbin Qu Qingxin Wu Muqing Fu Jiayi Zhong Jianwei Dong Sijie Chen Fan Wang Yuan Zhou Jie Zheng Wei Peng Jinsai Shang Xinwen Chen 
supported by the Natural Science Foundation of Guangdong province(Grant no.2024A1515011589 to Q.Y.);the National Natural Science Foundation of China(Grant no.32000111 to Q.Y.,82170473 to J.S.);the Pearl River Talent Recruitment Program(Grant no.2019CX01Y422 to X.C.);the Guangzhou Laboratory(Grant no.SRPG22-002 to J.S.and X.C.,No.SRPG22-011 to W.P.and Q.Y.);the Basic and Applied Basic Research Projects of Guangzhou Basic Research Program(2023A04J0161 to Q.Y.,2021QN020451 to J.S.);the Young Elite Scientists Sponsorship Program by CAST(Grant no.2023QNRC001 to F.L.).
Respiratory syncytial virus(RSV)is the major cause of bronchiolitis and pneumonia in young children and the elderly.There are currently no approved RSV-specific therapeutic small molecules available.Using high-through...
关键词:NEUTRAL METASTABLE approved 
检索报告 对象比较 聚类工具 使用帮助 返回顶部